BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30079293)

  • 1. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
    Jin P; Song Y; Yu G
    Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
    Qu PP; Shi Z; Li N
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
    Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
    Yang B; Yang ZG; Gao B; Shao GG; Li GH
    Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and significance of IKKε in the specimens and cells of epithelial ovarian cancer].
    Pang L; Gao JC; Zhang PX; Sun Q; Qi WJ; Gao HL; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jul; 52(7):483-489. PubMed ID: 28797156
    [No Abstract]   [Full Text] [Related]  

  • 6. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
    Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
    Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5-aza-2'-deoxycytidine on cell proliferation of non- small cell lung cancer cell line A549 cells and expression of the TFPI-2 gene.
    Dong YQ; Liang JS; Zhu SB; Zhang XM; Ji T; Xu JH; Yin GL
    Asian Pac J Cancer Prev; 2013; 14(7):4421-6. PubMed ID: 23992014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
    Bitler BG; Nicodemus JP; Li H; Cai Q; Wu H; Hua X; Li T; Birrer MJ; Godwin AK; Cairns P; Zhang R
    Cancer Res; 2011 Oct; 71(19):6184-94. PubMed ID: 21816908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW12, a novel F box protein-encoding gene, is deleted or methylated in some cases of epithelial ovarian cancer.
    De La Chesnaye E; Méndez JP; López-Romero R; De Los Angeles Romero-Tlalolini M; Vergara MD; Salcedo M; Ojeda SR
    Int J Clin Exp Pathol; 2015; 8(9):10192-203. PubMed ID: 26617728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer.
    Ding JJ; Wang G; Shi WX; Zhou HH; Zhao EF
    Reprod Sci; 2016 Jan; 23(1):24-30. PubMed ID: 26507869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
    Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
    Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
    Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
    BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic alteration of p16 and retinoic acid receptor beta genes in the development of epithelial ovarian carcinoma.
    Bhagat R; Kumar SS; Vaderhobli S; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
    Tumour Biol; 2014 Sep; 35(9):9069-78. PubMed ID: 24913706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
    Akahira J; Sugihashi Y; Suzuki T; Ito K; Niikura H; Moriya T; Nitta M; Okamura H; Inoue S; Sasano H; Okamura K; Yaegashi N
    Clin Cancer Res; 2004 Apr; 10(8):2687-93. PubMed ID: 15102672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
    Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing DNMT3A-mediated promoter methylation in ovarian cancer cells].
    Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.